[Current status of migraine chronification in Japan].

Rinsho Shinkeigaku

Division of Neurology, Department of Brain and Neurological Sciences, Faculty of Medicine, Tottori University.

Published: April 2015

Chronification of migraine headache is one of the major issues to resolve urgently. The prevalence of chronic migraine is close to 2%, and the chronification occurs in approximately 2.5% of episodic cases annually.The pathophysiology of transformation from episodic to chronic migraine is still unclear. It is considered that there are several risk factors for migraine chronification; 1) non-modifiable: age, low education/socioeconomic status, and head injury, 2) modifiable: attack frequency, obesity, medication overuse, stressful life events, caffeine overuse, snoring, and other pain syndrome, 3) currently putative: allodynia, proinflammatory states, prothrombotic states, and specific genes.There were a few clinical reports concerning to the migraine transformation from abroad, but few data from Japan. The prevalence of chronic daily headache in our headache clinic in Japan was 20-30%. The medication overuse headache was the most prevalent form in the highest attack frequency (>15 days/month) grope. Discontinuation of overused medication and administration of prophylactic medication were effective, and 40% of followed cases kept out of MOH at two years later.

Download full-text PDF

Source
http://dx.doi.org/10.5692/clinicalneurol.53.1223DOI Listing

Publication Analysis

Top Keywords

migraine chronification
8
prevalence chronic
8
chronic migraine
8
attack frequency
8
medication overuse
8
migraine
6
[current status
4
status migraine
4
chronification
4
chronification japan]
4

Similar Publications

Objective: To delineate the structural connectome alterations in patients with chronic migraine (CM), episodic migraine (EM), and healthy controls (HCs).

Background: The pathogenesis of migraine chronification remains elusive, with structural brain network changes potentially playing a key role. However, there is a paucity of research employing graph theory analysis to explore changes in the whole brain structural networks in patients with CM and EM.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the relationship between post-traumatic stress disorder (PTSD) and migraines, focusing on its prevalence in patients with episodic migraines (EM) and chronic migraines (CM).
  • The research involved 116 patients, finding that PTSD was more common in those with chronic migraines, and it significantly affected their quality of life and comorbidities like anxiety and depression.
  • The findings highlight the need for further studies to explore the impact of PTSD on migraines, particularly in cases linked to traumatic life events such as sexual violence.
View Article and Find Full Text PDF

: Genome-wide association studies (GWASs) demonstrate a complex genetic landscape for migraine risk. Migraine polygenic risk scores (PRSs) developed from GWAS data may have utility for predicting disease course. We analyzed the strength of association between an integrative migraine PRS and age at onset and chronification.

View Article and Find Full Text PDF

Objective: To evaluate long-term reductions in acute headache medication (AHM) use with eptinezumab versus placebo in patients with prior preventive migraine treatment failures and medication overuse (MO).

Background: Preventive migraine treatment is recommended for patients for whom AHMs have failed and for those who are using excessive amounts of AHM. MO may worsen headache and migraine symptoms in people with migraine; it is a risk factor for disease chronification and/or MO headache.

View Article and Find Full Text PDF

Conventional zolmitriptan (ZOL) has limited oral bioavailability, many adverse effects, and poor membrane penetrability that negatively influences its accessibility to its 5-HT receptor binding pocket, located transmemberanous. This work aimed at preparing transdermal ZOL-nanoformulation (niosomes) to surpass these limitations and to explore novel antimigraine mechanisms for ZOL via modulation of the epigenetically-altered chronification genes (RAMP-1, NPTX-2) or microRNAs and affecting the endocannabinoid CB-1/MAPK pathway. The prepared ZOL niosomes (F) exhibited %EE of 57.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!